Contraindicaciones de los esteroides inhalados

In December 2003, a new haemoglobin-based oxygen therapeutic, PolyHeme , began field tests in a Phase III trial on emergency patients (in trauma settings) in the . PolyHeme was the 15th experiment to be approved by the Food and Drug Administration since 1996. Patient consent is not necessary under the special category created by the FDA for these experiments. In late 2005, an independent panel verified, after the fourth and final review of 500 trauma patients enrolled in this study by that date, that no statistical evidence of safety concerns had arisen so far in the study. This study concluded in mid-2006 with final enrollment of 720 patients. Wired news reported that the trial failed when 47 of the 350 people given PolyHeme died compared to 35 deaths out of 363 in the control group. Debate exists as to whether or not the difference in the mortality rate is attributable to the small sample size. The fact that the experimental subjects did not give consent is a significant factor. [35]

Contraindicaciones de los esteroides inhalados

contraindicaciones de los esteroides inhalados

Media:

contraindicaciones de los esteroides inhaladoscontraindicaciones de los esteroides inhaladoscontraindicaciones de los esteroides inhaladoscontraindicaciones de los esteroides inhaladoscontraindicaciones de los esteroides inhalados

http://buy-steroids.org